Professor Hsiao-Chi Chuang's team's "ITIH4 protein drug technology developed through structural engineering for treating inflammation caused by eosinophils in the respiratory tract and reducing the severity of respiratory diseases" stood out in the 21st National Innovation Award for Academic and Research Innovation, gaining high recognition. This not only affirms the efforts of Professor Hsiao-Chi Chuang and his team but also highlights Taiwan's innovation and development potential in the field of biotechnology and medicine. With the further promotion and application of this technology, it is expected to bring benefits to more patients with respiratory diseases and attract widespread attention and research interest in the global medical community.